EU Agrees With Moderna on Accelerating Vaccine Deliveries to Jumpstart Booster Programs

© AFP 2022 / JOSEPH PREZIOSOIn this file photo the Moderna logo is seen at the Moderna campus in Norwood, Massachusetts on on December 2, 2020, where the biotechnology company is mass producing its Covid-19 vaccine. - US biotech firm Moderna said on July 7, 2021 it had dosed its first participants in a human study of an mRNA vaccine that targets multiple strains of influenza. The company intends to recruit 180 adults in the United States for the Phase 1/2 portion of the trial to evaluate the safety and strength of immune response to the shot, called mRNA-1010.
In this file photo the Moderna logo is seen at the Moderna campus in Norwood, Massachusetts on on December 2, 2020, where the biotechnology company is mass producing its Covid-19 vaccine. - US biotech firm Moderna said on July 7, 2021 it had dosed its first participants in a human study of an mRNA vaccine that targets multiple strains of influenza. The company intends to recruit 180 adults in the United States for the Phase 1/2 portion of the trial to evaluate the safety and strength of immune response to the shot, called mRNA-1010. - Sputnik International, 1920, 16.12.2021
Subscribe
International
India
Africa
MOSCOW (Sputnik) - The European Commission (EC) has agreed on Thursday with Moderna to speed up deliveries of vaccines to countries that urgently need doses for their booster programs, in particular Germany.
"Moderna agreed to anticipate the delivery of 10 million doses to December for Germany. This is the equivalent of 20 million persons receiving a booster – as only half a dose is used for a booster," the statement read.
Additionally, the pharmaceutical company will deliver 25 million extra doses to Germany in the first quarter of 2022, which is equivalent to 50 million boosters, the EC said. Other countries will also benefit from accelerated Moderna vaccine deliveries at the beginning of 2022, the Commission added.
The move is to ensure that the EU members can quickly roll out booster vaccination programs to prevent the spread of the new Omicron coronavirus variant.
Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала